Randomized phase II trial evaluating treatment with EGFR-TKI versus EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial.

Affiliation auteurs!!!! Error affiliation !!!!
TitreRandomized phase II trial evaluating treatment with EGFR-TKI versus EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial.
Type de publicationJournal Article
Year of Publication2018
AuteursMazieres J, Barlesi F, Rouquette I, Besse B, Monnet I, Audigier-Valette C, Toffart AClaire, Renault P-A, Fraboulet SMoreau, Hiret S, Mennecier B, Debieuvre D, Westeel V, Masson P, Madroszyk A, Amour E, Morin F, Zalcman G, Moro-Sibilot D, Souquet PJean
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume36
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2018.36.15_suppl.9097